This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Clostridium chauvoei Putative Hemolysin A, N-GST
Product Overview
BioVenic's Recombinant Clostridium chauvoei Putative Hemolysin A, N-GST is a recombinant protein expressed from E.coli. Its predicted molecular weight is 60.0 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
In the veterinary field, Clostridium chauvoei putative hemolysin A is a significant toxin, a β-barrel pore-forming toxin belonging to the leucocidin superfamily of bacterial toxins. CctA is one of the main toxins causing blackleg disease in animals, with strong hemolytic and cytotoxic properties, showing high cytotoxicity to the bovine epithelial cell line ECaNEp. In vaccine development, CctA serves as a major protective antigen, inducing neutralizing antibodies against infections caused by C. chauvoei, making it a key component of vaccines and immunization strategies.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.Aliquote the reconstituted solution to minimise freeze-thaw cycles.